Comments
Loading...

SAB Biotherapeutics

SABSNASDAQ
Logo brought to you by Benzinga Data
$2.56
-0.21-7.58%
At Close: -
$2.80
0.249.37%
After Hours: Sep 16, 7:00 AM EDT
15 minutes delayed

SAB Biotherapeutics (NASDAQ:SABS) Stock, Earnings Estimates, EPS, And Revenue

SAB Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 11
EPS Estimate
$-1.070
Quarterly Revenue Estimate
$170K
Annual Revenue
(as of Jun 30)

Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

SAB Biotherapeutics (SABS) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-08$-0.79$-1.0323.3 %
Mar 20242024-05-20$-0.54$-0.46-17.4 %
Dec 20232024-03-29$-3.84$-0.62-519.4 %
Sep 20232023-11-13$-1.00$-1.2016.7 %

SAB Biotherapeutics (SABS) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20232023-11-13$1.27M$20.00K6235.0 %
Mar 20232023-05-16$581.10K$2.36M-75.4 %
Mar 20232023-04-14$2.16M$6.50M-66.8 %
Sep 20222022-11-15$3.59M$6.85M-47.6 %

FAQ

Q

When is SAB Biotherapeutics (NASDAQ:SABS) reporting earnings?

A

SAB Biotherapeutics (SABS) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for SAB Biotherapeutics (NASDAQ:SABS)?

A

The Actual EPS was $-0.79, which beat the estimate of $-1.03.

Q

What were SAB Biotherapeutics’s (NASDAQ:SABS) revenues?

A

The Actual Revenue was $263.1K, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch